Dimethyl fumarate Accord Evrópusambandið - íslenska - EMA (European Medicines Agency)

dimethyl fumarate accord

accord healthcare s.l.u. - dímetýl fúmarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - Ónæmisbælandi lyf - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Metoprololsuccinat Hexal Forðatafla 100 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

metoprololsuccinat hexal forðatafla 100 mg

hexal a/s - metoprololum súkkínat - forðatafla - 100 mg

Metoprololsuccinat Hexal Forðatafla 25 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

metoprololsuccinat hexal forðatafla 25 mg

hexal a/s - metoprololum súkkínat - forðatafla - 25 mg

Metoprololsuccinat Hexal Forðatafla 50 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

metoprololsuccinat hexal forðatafla 50 mg

hexal a/s - metoprololum súkkínat - forðatafla - 50 mg

Aubagio Evrópusambandið - íslenska - EMA (European Medicines Agency)

aubagio

sanofi winthrop industrie - teriflunomide - margvísleg sclerosis - valdar ónæmisbælandi lyf - aubagio is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).

Teriflunomide Mylan Evrópusambandið - íslenska - EMA (European Medicines Agency)

teriflunomide mylan

mylan pharmaceuticals limited - teriflunomide - heila-og mænusigg, köstum tilkynnt - Ónæmisbælandi lyf - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).

Teriflunomide Accord Evrópusambandið - íslenska - EMA (European Medicines Agency)

teriflunomide accord

accord healthcare s.l.u. - teriflunomide - heila-og mænusigg, köstum tilkynnt - Ónæmisbælandi, sérhæfður ónæmisbælandi - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).

Teriflunomide Sandoz Filmuhúðuð tafla 14 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

teriflunomide sandoz filmuhúðuð tafla 14 mg

sandoz a/s - teriflunomidum inn - filmuhúðuð tafla - 14 mg

Fampyra Evrópusambandið - íslenska - EMA (European Medicines Agency)

fampyra

biogen netherlands b.v.  - fampridine - margvísleg sclerosis - Önnur lyf í taugakerfinu - fampyra er ætlað til að bæta gangandi meðferð hjá fullorðnum sjúklingum með ms með göngudeildum (stækkuð örorkustöð skala 4-7).

Fampridine Accord Evrópusambandið - íslenska - EMA (European Medicines Agency)

fampridine accord

accord healthcare s.l.u. - fampridine - margvísleg sclerosis - Önnur lyf í taugakerfinu - fampridine accord is indicated for the improvement of walking in adult patients with multiple sclerosis with walking disability (edss 4-7).